Lymphoproliferative syndrome
MONDO:0016537A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).
Also known as: lymphoproliferative disorder, lymphoproliferative syndrome
138 clinical trials for this condition and its sub-types, 70 tagged with Lymphoproliferative syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoproliferative syndrome
-
Castleman disease 8 trials · 18 incl. sub-types
4 sub-types
- Multicentric Castleman disease 13 trials
- Idiopathic multicentric Castleman disease 3 trials Sub-types →
- Localized Castleman disease 1 trial
- Pediatric Castleman disease 0 trials
-
Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types
9 sub-types
- Autoimmune lymphoproliferative syndrome type 4 3 trials
- FAS-related autoimmune lymphoproliferative syndrome 2 trials
- Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency 1 trial
- Castleman-Kojima disease 0 trials
- Autoimmune lymphoproliferative syndrome type 1 0 trials
- Autoimmune lymphoproliferative syndrome type 2A 0 trials
- Autoimmune lymphoproliferative syndrome type 2B 0 trials
- Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD 0 trials
- Type 3 autoimmune lymphoproliferative syndrome 0 trials
-
X-linked lymphoproliferative syndrome 7 trials · 11 incl. sub-types
2 sub-types
-
Lymphoproliferative syndrome 1 0 trials
-
Lymphoproliferative syndrome 2 0 trials